Alterations in PI3K/AKT/mTOR pathway were reported in 42% and 100% of primary and metastatic PCa, respectively [21], which is in line with downregulation of AKT, phospho-AKT and mTOR upon PRMT6 silencing. Here, PRMT6 is linked to posterior cortical atrophy.